Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
R Chin, Kevin Chen, Abul Usmani, et al.
Molecular Diagnosis & Therapy (2019) Vol. 23, Iss. 3, pp. 311-331
Open Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
Thomas Powles, Zoe J. Assaf, Nicole N. Davarpanah, et al.
Nature (2021) Vol. 595, Iss. 7867, pp. 432-437
Closed Access | Times Cited: 447
Molecular Probes, Chemosensors, and Nanosensors for Optical Detection of Biorelevant Molecules and Ions in Aqueous Media and Biofluids
Joana Krämer, Rui Kang, Laura Grimm, et al.
Chemical Reviews (2022) Vol. 122, Iss. 3, pp. 3459-3636
Open Access | Times Cited: 281
Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease
Everett J. Moding, Barzin Y. Nabet, Ash A. Alizadeh, et al.
Cancer Discovery (2021) Vol. 11, Iss. 12, pp. 2968-2986
Open Access | Times Cited: 193
Cancer evolution: Darwin and beyond
Roberto Vendramin, Kevin Litchfield, Charles Swanton
The EMBO Journal (2021) Vol. 40, Iss. 18
Open Access | Times Cited: 175
Application of Next Generation Sequencing in Laboratory Medicine
Yiming Zhong, Feng Xu, Jinhua Wu, et al.
Annals of Laboratory Medicine (2020) Vol. 41, Iss. 1, pp. 25-43
Open Access | Times Cited: 159
Circulating Tumor DNA Minimal Residual Disease Detection of Non–Small-Cell Lung Cancer Treated With Curative Intent
Bruna Pellini, Aadel A. Chaudhuri
Journal of Clinical Oncology (2022) Vol. 40, Iss. 6, pp. 567-575
Open Access | Times Cited: 134
Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
Yan Peng, Wuxuan Mei, Kaidong Ma, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 106
Liquid biopsy in gliomas: A RANO review and proposals for clinical applications
Riccardo Soffietti, Chetan Bettegowda, Ingo K. Mellinghoff, et al.
Neuro-Oncology (2022) Vol. 24, Iss. 6, pp. 855-871
Open Access | Times Cited: 78
Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer
Ellen Heitzer, Daan van den Broek, Marc G. Denis, et al.
ESMO Open (2022) Vol. 7, Iss. 2, pp. 100399-100399
Open Access | Times Cited: 78
Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
Pashtoon Murtaza Kasi, Gordon Fehringer, Hiroya Taniguchi, et al.
JCO Precision Oncology (2022), Iss. 6
Open Access | Times Cited: 71
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
James R. Black, Gábor Bartha, Charles W. Abbott, et al.
Nature Medicine (2025)
Open Access | Times Cited: 6
Liquid biopsy technologies: innovations and future directions in breast cancer biomarker detection
L. Cao, Qiaohong Duan, Zixin Zhu, et al.
Biomedical Microdevices (2025) Vol. 27, Iss. 1
Closed Access | Times Cited: 1
Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA
Vicky Rowlands, Andrzej Rutkowski, Elena Meuser, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 94
Liquid Biopsy, ctDNA Diagnosis through NGS
Lin Chen, Xuzhu Liu, Bingyi Zheng, et al.
Life (2021) Vol. 11, Iss. 9, pp. 890-890
Open Access | Times Cited: 73
Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study
Pradeep S. Chauhan, Kevin Chen, Ramandeep K. Babbra, et al.
PLoS Medicine (2021) Vol. 18, Iss. 8, pp. e1003732-e1003732
Open Access | Times Cited: 68
Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study
Jeffrey J. Szymanski, R. Taylor Sundby, Paul A. Jones, et al.
PLoS Medicine (2021) Vol. 18, Iss. 8, pp. e1003734-e1003734
Open Access | Times Cited: 60
Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer
Maria F. Arisi, Efrat Dotan, Sandra V. Fernandez
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4441-4441
Open Access | Times Cited: 49
Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer
Vincenza Caputo, Fortunato Ciardiello, Carminia M. Della Corte, et al.
Exploration of Targeted Anti-tumor Therapy (2023), pp. 102-138
Open Access | Times Cited: 37
Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA
Nicholas P. Semenkovich, Jeffrey J. Szymanski, Noah Earland, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006284-e006284
Open Access | Times Cited: 31
Next-Generation sequencing transforming clinical practice and precision medicine
Deepali Yadav, Bhagyashri Patil‐Takbhate, Anil Khandagale, et al.
Clinica Chimica Acta (2023) Vol. 551, pp. 117568-117568
Closed Access | Times Cited: 24
Biomarker-specific biosensors revolutionise breast cancer diagnosis
Mugip Rahaman Abdul Wahab, Thirunavukkarasu Palaniyandi, Sandhiya Viswanathan, et al.
Clinica Chimica Acta (2024) Vol. 555, pp. 117792-117792
Closed Access | Times Cited: 11
Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma
Étienne Buscail, Charlotte Maulat, Fabrice Muscari, et al.
Cancers (2019) Vol. 11, Iss. 6, pp. 852-852
Open Access | Times Cited: 62
Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer
Chiang‐Ching Huang, Meijun Du, Liang Wang
Cancers (2019) Vol. 11, Iss. 6, pp. 805-805
Open Access | Times Cited: 60
Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects
Dekker C. Deacon, Eric A. Smith, Robert L. Judson‐Torres
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 45
Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact
Natasha Honoré, Rachel Galot, Cédric van Marcke, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5364-5364
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top